INTERPARFUMS, INC. (IPAR) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 287.32M USD | Liabilities, Current |
| Cash and equivalents | (m) | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 301.83M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 375.58M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $287.32M | (m) | (m) | $301.83M | $375.58M | (m) |
| 2026-03-31 | (m) | $305.93M | (m) | (m) | $332.73M | $369.63M | (m) |
| 2025-12-31 | (m) | $344.00M | (m) | (m) | $320.63M | $351.38M | (m) |
| 2025-09-30 | (m) | $302.77M | (m) | (m) | $363.62M | $388.30M | (m) |
| 2025-06-30 | (m) | $333.00M | (m) | (m) | $296.04M | $425.35M | (m) |
| 2025-03-31 | (m) | $306.45M | (m) | (m) | $302.27M | $395.89M | (m) |
| 2024-12-31 | (m) | $332.43M | (m) | (m) | $274.70M | $371.92M | (m) |
| 2024-09-30 | (m) | $339.58M | (m) | (m) | $354.18M | $412.76M | (m) |
| 2024-06-30 | (m) | $332.44M | (m) | (m) | $299.38M | $433.72M | (m) |
| 2024-03-31 | (m) | $302.46M | (m) | (m) | $293.07M | $400.21M | (m) |
| 2023-12-31 | (m) | $324.75M | (m) | (m) | $247.24M | $371.86M | (m) |
| 2023-09-30 | (m) | $363.10M | $79.76M | (m) | $288.08M | $364.27M | (m) |
| 2023-06-30 | (m) | $341.67M | $74.31M | (m) | $236.55M | $360.02M | (m) |
| 2023-03-31 | (m) | $362.17M | (m) | (m) | $241.95M | $323.70M | (m) |
| 2022-12-31 | (m) | $344.57M | (m) | (m) | $197.58M | $289.98M | (m) |
| 2022-09-30 | (m) | $248.51M | $41.28M | (m) | $220.11M | $283.24M | (m) |
| 2022-06-30 | (m) | $235.50M | $52.23M | (m) | $192.55M | $265.83M | (m) |
| 2022-03-31 | (m) | $250.23M | $110.12M | (m) | $206.26M | $227.11M | (m) |
| 2021-12-31 | (m) | $244.91M | $168.39M | (m) | $159.28M | $198.91M | (m) |
| 2021-09-30 | (m) | $212.35M | $174.85M | (m) | $193.87M | $156.03M | (m) |
| 2021-06-30 | (m) | $218.19M | $149.71M | (m) | $176.54M | $163.48M | (m) |
| 2021-03-31 | (m) | $152.11M | $143.31M | (m) | $149.94M | $148.69M | (m) |
| 2020-12-31 | (m) | $156.21M | $169.68M | (m) | $124.06M | $158.82M | (m) |
| 2020-09-30 | (m) | $119.25M | $133.35M | (m) | $138.49M | $178.85M | (m) |
| 2020-06-30 | (m) | $101.97M | $127.46M | (m) | $77.40M | $194.83M | (m) |
| 2020-03-31 | (m) | $145.51M | $142.56M | (m) | $133.64M | $169.48M | (m) |
| 2019-12-31 | (m) | $184.47M | $192.42M | (m) | $133.01M | $167.81M | (m) |
| 2019-09-30 | (m) | $167.91M | $138.46M | (m) | $173.84M | $167.11M | (m) |
| 2019-06-30 | (m) | $178.60M | $146.79M | (m) | $147.83M | $180.06M | (m) |
| 2019-03-31 | (m) | $183.78M | $156.38M | (m) | $167.28M | $165.39M | (m) |
| 2018-12-31 | (m) | $186.98M | $193.14M | (m) | $136.42M | $160.98M | (m) |
| 2018-09-30 | (m) | $162.37M | $133.55M | (m) | $164.57M | $161.46M | (m) |
| 2018-06-30 | (m) | $171.47M | $145.32M | (m) | $140.03M | $169.32M | (m) |
| 2018-03-31 | (m) | $169.94M | $168.93M | (m) | $166.08M | $141.25M | (m) |
| 2017-12-31 | (m) | $167.11M | $208.34M | (m) | $120.75M | $137.06M | (m) |
| 2017-09-30 | (m) | $157.85M | $108.37M | (m) | $159.43M | $134.28M | (m) |
| 2017-06-30 | (m) | $151.90M | $116.77M | (m) | $119.36M | $136.91M | (m) |
| 2017-03-31 | (m) | $148.39M | $109.83M | (m) | $139.88M | $111.32M | (m) |
| 2016-12-31 | (m) | $142.24M | $161.83M | (m) | $104.82M | $96.98M | (m) |
| 2016-09-30 | (m) | $132.46M | $95.95M | (m) | $145.74M | $105.30M | (m) |
| 2016-06-30 | (m) | $137.11M | $115.85M | (m) | $101.00M | $124.25M | (m) |
| 2016-03-31 | (m) | $133.11M | $151.46M | (m) | $107.61M | $112.89M | (m) |
| 2015-12-31 | (m) | $131.08M | $176.97M | (m) | $95.08M | $98.35M | (m) |
| 2015-09-30 | (m) | $117.04M | $124.53M | (m) | $130.24M | $106.99M | (m) |
| 2015-06-30 | (m) | $114.37M | $76.93M | (m) | $89.49M | $122.35M | (m) |
| 2015-03-31 | (m) | $101.97M | $87.24M | (m) | $96.39M | $104.55M | (m) |
| 2014-12-31 | (m) | $103.63M | $90.14M | (m) | $90.12M | $102.33M | (m) |
| 2014-09-30 | (m) | $105.13M | $50.19M | (m) | $122.22M | $112.86M | (m) |
| 2014-06-30 | (m) | $101.93M | $60.15M | (m) | $96.12M | $125.53M | (m) |
| 2014-03-31 | (m) | $104.46M | $45.59M | (m) | $100.41M | $117.96M | (m) |
| 2013-12-31 | (m) | $126.15M | $125.65M | (m) | $79.93M | $117.35M | (m) |
| 2013-09-30 | (m) | $111.86M | $137.15M | (m) | $116.47M | $110.48M | (m) |
| 2013-06-30 | (m) | $113.42M | $142.12M | (m) | $124.10M | $112.64M | (m) |
| 2013-03-31 | (m) | $230.61M | $146.21M | (m) | $190.22M | $110.83M | (m) |
| 2012-12-31 | (m) | $256.14M | $307.33M | (m) | $149.34M | $142.61M | (m) |
| 2012-09-30 | (m) | $132.00M | $25.85M | (m) | $167.21M | $161.06M | (m) |
| 2012-06-30 | (m) | $132.91M | $23.13M | (m) | $139.33M | $175.75M | (m) |
| 2012-03-31 | (m) | $163.65M | $27.41M | (m) | $164.03M | $183.93M | (m) |
| 2011-12-31 | (m) | $185.62M | $35.86M | (m) | $175.22M | $164.08M | (m) |
| 2011-09-30 | (m) | $183.10M | $23.18M | (m) | $167.63M | $182.30M | (m) |
| 2011-06-30 | (m) | $153.42M | $38.77M | (m) | $118.24M | $176.31M | (m) |
| 2011-03-31 | (m) | (m) | $40.98M | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $126.33M | $37.55M | (m) | $97.59M | $109.84M | (m) |
| 2010-09-30 | (m) | (m) | $48.67M | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $58.67M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $100.47M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $42.40M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COTY INC. (COTY) | United States | $2.307B | -3.15 |
| e.l.f. Beauty, Inc. (ELF) | United States | $5.934B | |
| EDGEWELL PERSONAL CARE Co (EPC) | United States | $1.261B | -13.27 |
| SOLESENCE, INC. (SLSN) | United States | $0.058B | -25.13 |
| Axil Brands, Inc. (AXIL) | United States | $0.042B | 17.24 |
| UNITED GUARDIAN INC (UG) | United States | $0.034B | 13.30 |
| Caring Brands, Inc. (CABR) | United States | $0.013B | |
| BONK, INC. (BNKK) | United States | $0.011B | -0.14 |
| cbdMD, Inc. (YCBD) | United States | $0.005B | -2.59 |
| Kenvue Inc. (KVUE) | United States | $33.844B | 22.14 |